This article is reproduced from [CCTV];
CCTV news: In the ninth edition of the diagnosis and treatment plan for new coronary pneumonia released on March 15, the State Food and Drug Administration approved the The specific anti-new coronavirus drugs of nermatvir tablets and ritonavir tablets are written in it.
On the evening of the 17th, the first batch of 21,200 naimatevir tablets ritonavir approved by the State Food and Drug Administration The tablet-specific anti-coronavirus drugs entered the port at Pudong Airport, were inspected and released by the Shanghai Waigaoqiao Free Trade Zone Customs, completed the customs clearance procedures, and were quickly transported to the national front line of anti-epidemic.
At the press conference of the State Council’s Joint Prevention and Control Mechanism on March 19, experts introduced that these two newly approved antiviral drugs will effectively reduce the probability of patients with new coronary pneumonia from mild to severe, thereby reducing the risk of infection. Improve the rescue rate.
Li Xingwang, chief expert of the Infectious Diseases Diagnosis and Research Center of Beijing Ditan Hospital: These two drugs have been included in the new version of the diagnosis and treatment plan. We are very concerned about the treatment of COVID-19 (pneumonia). One of the problems is how to prevent patients from changing from mild to severe, and how to reduce the severe rate and fatality rate, thereby increasing the treatment rate. These two drugs provide such a weapon. It can be seen from the results of the preliminary clinical research data that these two drugs may become severe or have a high fatality rate among the so-called mild and ordinary patients. If they are used within 5 days of the onset, their hospitalization rate and case fatality rate will be higher. Significantly lower, which is just in line with clinical needs. Therefore, I think that after these two drugs are included in the diagnosis and treatment plan, doctors have these drugs in their hands, which will have a great effect on improving the treatment rate and reducing the mortality rate.